Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
about
Renal replacement therapy in acute kidney injury: controversy and consensusThe incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients.Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs.CRRTnet: a prospective, multi-national, observational study of continuous renal replacement therapy practices.Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!Citrate for continuous renal replacement therapy: safer, better and cheaper.Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalitiesImplementation of continuous renal replacement therapy with regional citrate anticoagulation on a surgical and trauma intensive care unit: impact on clinical and economic aspects-an observational study.Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials.Citrate anticoagulation for CRRT: don't always trust the postfilter iCa results!Insights about serum sodium behavior after 24 hours of continuous renal replacement therapyRegional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.Is Regional Citrate Anticoagulation the Future of Hemodialysis?Transition From Heparin to Citrate Anticoagulation for Continuous Renal Replacement Therapy: Safety, Efficiency, and Cost.[Treatment of acute renal failure in Germany: Analysis of current practice].Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney InjuryComplications of regional citrate anticoagulation: accumulation or overload?Clinical impact of regional citrate anticoagulation in continuous renal replacement therapy in critically ill patients.Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy.Concentration-dependent effect of hypocalcaemia on in vitro clot strength in patients at risk of bleeding: a retrospective cohort study.Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.A novel citrate-based protocol versus heparin anticoagulation for sustained low-efficiency dialysis in the ICU: safety, efficacy, and cost.Protection of resveratrol on acute kidney injury in septic rats.Fluid balance-adjusted creatinine at initiation of continuous venovenous hemofiltration and mortality. A post-hoc analysis of a multicenter randomized controlled trial.The Japanese Clinical Practice Guideline for acute kidney injury 2016
P2860
Q26998864-0C54E8F0-37E9-4909-B6B1-F2BDA68B7F94Q33423870-685A7D6B-EC56-44F8-AEBA-DE1828588084Q33426850-C1570D1F-D048-4D37-BD5F-47E3174F03D6Q33882611-C0974FF0-E801-4D9E-91A8-682BFC99B5A9Q35060066-133FD591-651B-45B3-BCD4-FDEC05834547Q35091035-D215D2F8-EB98-401E-86EF-B49CDB6B7467Q35190273-1FE62418-1678-4DDF-B9C2-B59BB04E2FA4Q35827976-98F85A2F-AE27-4203-A381-2E46FC8801BFQ35902914-E290D07B-1914-442E-9CF1-D15E48D190FAQ36017130-67E0E0DF-833A-4542-87A2-5DDE5F7A13A2Q36346759-89F4733B-1BC1-4B0C-9B42-9AFE77E79FDDQ37090211-05F45028-B9B4-4829-A708-614F7A6330ADQ38632428-2FF5A749-4723-4C49-BD59-97EB57F56DE8Q38851933-27A1CD8B-0A3B-46DC-BCC4-5EE2BF2426ACQ40112499-2DE3A6B6-528E-4C55-BB8B-486CEB081187Q41372436-FC211229-1E27-467F-9CAD-31220BA9F814Q42030808-1B720008-77C8-4FDD-8B22-A750DC2AEDE5Q46518144-4127B4B3-62AC-427F-A0ED-7464123602FDQ47195267-DAE17E45-CF81-4363-8ADD-9FFCD6A79D10Q47903052-07543121-7FC5-43B2-A1A6-39C64198758BQ48270015-F5D3D234-7BCA-482E-853D-2F829A9C86A8Q51018006-359984E2-CD2B-425F-B545-C2015FC7CC84Q52333189-81F3E767-4880-49DC-AA5C-18F8512119EAQ54488034-0CF0790A-EAE1-4E58-A468-BF4422E97782Q55069271-14D13489-E7E2-4A54-BDF7-0C86A0859081Q58787383-F47BED96-B854-4B3A-8EB6-A42715C9F35E
P2860
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Citrate anticoagulation versus ...... ter randomized clinical trial.
@ast
Citrate anticoagulation versus ...... ter randomized clinical trial.
@en
Citrate anticoagulation versus ...... ter randomized clinical trial.
@nl
type
label
Citrate anticoagulation versus ...... ter randomized clinical trial.
@ast
Citrate anticoagulation versus ...... ter randomized clinical trial.
@en
Citrate anticoagulation versus ...... ter randomized clinical trial.
@nl
prefLabel
Citrate anticoagulation versus ...... ter randomized clinical trial.
@ast
Citrate anticoagulation versus ...... ter randomized clinical trial.
@en
Citrate anticoagulation versus ...... ter randomized clinical trial.
@nl
P2093
P2860
P1433
P1476
Citrate anticoagulation versus ...... ter randomized clinical trial.
@en
P2093
A B Johan Groeneveld
Albertus Beishuizen
Armand R J Girbes
CASH study group
Cynthia G Kleppe
Frank H Bosch
Ilse M Purmer
Louise Schilder
Marc G Vervloet
Pieter M Ter Wee
P2860
P2888
P356
10.1186/S13054-014-0472-6
P577
2014-08-16T00:00:00Z
P5875
P6179
1012475837